Starmap Medicine & Technology Co Ltd operates within the Food crops grown under cover sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Starmap Medicine & Technology Co Ltd with three other
fruit and vegetable producers in Asia:
China Greenfresh Group Co Ltd
of Hong Kong
sales of 1.27 billion Hong Kong Dollars [US$162.25 million]
of which 37%
Tianshui Zhongxing Bio-technology Co Ltd
(585.02 million Chinese Renmimbi [US$88.38 million]
of which 100%
was Planting), and
Shanghai Xuerong Bio-Technology Co Ltd
(998.56 million Chinese Renmimbi [US$150.86 million]
of which 99%
was Edible fungi industry).
During the year ended December of 2016, sales at
Starmap Medicine & Technology Co Ltd were 432.45 million Chinese Renmimbi (US$65.34 million).
increase of 54.4%
versus 2015, when the company's sales were 280.14 million Chinese Renmimbi.